The pharmacological treatment of patients with an eating disorder (ED) often includes
medications to treat their ED, comorbid mental health problems, malnutrition and the …

Inhibitors of the IL-6 signaling pathway, such as tocilizumab, are frequently administered for
the treatment of immune diseases, eg, rheumatoid arthritis and multicentric Castleman's …

Obesity is a growing epidemic worldwide, and it is also considered a major environmental
factor contributing to the pathogenesis of inflammatory skin diseases, including psoriasis …

Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) is intended to provide clinicians an overview of the body weight effects of concomitant …

Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis,
has become increasingly prevalent worldwide in the past decade. The nutritional status of …

The equilibrium and reciprocal actions among appetite-stimulating (orexigenic) and appetite-
suppressing (anorexigenic) signals synthesized in the gut, brain, microbiome and adipose …

Childhood obesity is the public health issue with alarming rates recorded throughout
developed world and an important modifiable health risk for developing various chronic …

Introduction: Anorexia nervosa (AN) is an often chronic and debilitating psychiatric disease
whose aetiology is not completely understood. Recently, a potential role of inflammation has …

Growth delay with height and weight impairment is a common feature of pediatric
inflammatory bowel diseases (PIBD). Up to 2/3 of Crohn Disease patients have impaired …

There is growing interest in the role that the intestinal microbiota and the related
autoimmune processes may have in the genesis and presentation of some psychiatric …